Harbor Investment Advisory’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-84
Closed -$1K 1329
2022
Q2
$1K Sell
84
-150
-64% -$2.1K ﹤0.01% 1282
2022
Q1
$5K Buy
234
+5
+2% +$122 ﹤0.01% 1158
2021
Q4
$6K Buy
229
+79
+53% +$2.12K ﹤0.01% 1116
2021
Q3
$4K Buy
+150
New +$4.25K ﹤0.01% 1164
2021
Q1
Sell
-1,200
Closed -$25K 1255
2020
Q4
$25K Sell
1,200
-200
-14% -$3.73K ﹤0.01% 781
2020
Q3
$22K Hold
1,400
﹤0.01% 713
2020
Q2
$26K Hold
1,400
0.01% 573
2020
Q1
$22K Buy
1,400
+200
+17% +$4.82K 0.01% 557
2019
Q4
$36K Buy
+1,200
New +$31.2K 0.01% 461

Other funds holding BHC

Harbor Investment Advisory's BHC Position: Q3 2022 in Review

Harbor Investment Advisory sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 84 shares — an estimated $1K sold.

Harbor Investment Advisory first reported a position in BHC in Q4 2019 and held it in 9 quarters. The position peaked at $36K in Q4 2019. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Harbor Investment Advisory reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Harbor Investment Advisory sold 84 Bausch Health shares in Q3 2022, an estimated $1K.
  • Harbor Investment Advisory first reported a position in Bausch Health in Q4 2019 and held it in 9 quarters.
  • Harbor Investment Advisory's Bausch Health position peaked at $36K in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Harbor Investment Advisory's 13F filing for Q3 2022, filed 1 Nov 2022.